181 related articles for article (PubMed ID: 35245483)
81. Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
Vihinen M; Mattsson PT; Smith CI
Front Biosci; 2000 Dec; 5():D917-28. PubMed ID: 11102316
[TBL] [Abstract][Full Text] [Related]
82. Splice-correction strategies for treatment of X-linked agammaglobulinemia.
Bestas B; Turunen JJ; Blomberg KE; Wang Q; Månsson R; El Andaloussi S; Berglöf A; Smith CI
Curr Allergy Asthma Rep; 2015 Mar; 15(3):510. PubMed ID: 25638286
[TBL] [Abstract][Full Text] [Related]
83. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis.
Kanegane H; Futatani T; Wang Y; Nomura K; Shinozaki K; Matsukura H; Kubota T; Tsukada S; Miyawaki T
J Allergy Clin Immunol; 2001 Dec; 108(6):1012-20. PubMed ID: 11742281
[TBL] [Abstract][Full Text] [Related]
84. [Genetic study of an X-linked agammaglobulinemia pedigree caused by an BTK mutation].
Wei C; Yang R; Yuan X; Yu S; Qin J; Tian X; Zhang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Nov; 38(11):1081-1086. PubMed ID: 34729748
[TBL] [Abstract][Full Text] [Related]
85. Impact of amino acid substitution in the kinase domain of Bruton tyrosine kinase and its association with X-linked agammaglobulinemia.
Mohammad T; Amir M; Prasad K; Batra S; Kumar V; Hussain A; Rehman MT; AlAjmi MF; Hassan MI
Int J Biol Macromol; 2020 Dec; 164():2399-2408. PubMed ID: 32784026
[TBL] [Abstract][Full Text] [Related]
86. Potential application of gene therapy to X-linked agammaglobulinemia.
Moreau T; Calmels B; Barlogis V; Michel G; Tonnelle C; Chabannon C
Curr Gene Ther; 2007 Aug; 7(4):284-94. PubMed ID: 17969561
[TBL] [Abstract][Full Text] [Related]
87. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
Vihinen M; Belohradsky BH; Haire RN; Holinski-Feder E; Kwan SP; Lappalainen I; Lehväslaiho H; Lester T; Meindl A; Ochs HD; Ollila J; Vorechovsky I; Weiss M; Smith CI
Nucleic Acids Res; 1997 Jan; 25(1):166-71. PubMed ID: 9016530
[TBL] [Abstract][Full Text] [Related]
88. Characterization of mutations, including a novel regulatory defect in the first intron, in Bruton's tyrosine kinase gene from seven Korean X-linked agammaglobulinemia families.
Jo EK; Kanegane H; Nonoyama S; Tsukada S; Lee JH; Lim K; Shong M; Song CH; Kim HJ; Park JK; Miyawaki T
J Immunol; 2001 Oct; 167(7):4038-45. PubMed ID: 11564824
[TBL] [Abstract][Full Text] [Related]
89. Genotype-phenotype correlation in Bruton's tyrosine kinase deficiency.
Teimourian S; Nasseri S; Pouladi N; Yeganeh M; Aghamohammadi A
J Pediatr Hematol Oncol; 2008 Sep; 30(9):679-83. PubMed ID: 18776760
[TBL] [Abstract][Full Text] [Related]
90. Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA).
Jin H; Webster AD; Vihinen M; Sideras P; Vorechovsky I; Hammarstróm L; Bernatowska-Matuszkiewicz E; Smith CI; Bobrow M; Vetrie D
Hum Mol Genet; 1995 Apr; 4(4):693-700. PubMed ID: 7633420
[TBL] [Abstract][Full Text] [Related]
91. Atypical X-linked agammaglobulinemia diagnosed in three adults.
Hashimoto S; Miyawaki T; Futatani T; Kanegane H; Usui K; Nukiwa T; Namiuchi S; Matsushita M; Yamadori T; Suemura M; Kishimoto T; Tsukada S
Intern Med; 1999 Sep; 38(9):722-5. PubMed ID: 10480303
[TBL] [Abstract][Full Text] [Related]
92. Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia.
Martignani C; Massaro G; Bruno AG; Biffi M; Ziacchi M; Diemberger I
Immunobiology; 2020 Jan; 225(1):151861. PubMed ID: 31740078
[TBL] [Abstract][Full Text] [Related]
93. A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia.
López-Granados E; Pérez de Diego R; Ferreira Cerdán A; Fontán Casariego G; García Rodríguez MC
J Allergy Clin Immunol; 2005 Sep; 116(3):690-7. PubMed ID: 16159644
[TBL] [Abstract][Full Text] [Related]
94. Dried Blood Spots, an Affordable Tool to Collect, Ship, and Sequence gDNA from Patients with an X-Linked Agammaglobulinemia Phenotype Residing in a Developing Country.
Segundo GRS; Nguyen ATV; Thuc HT; Nguyen LNQ; Kobayashi RH; Le HT; Le HTM; Torgerson TR; Ochs HD
Front Immunol; 2018; 9():289. PubMed ID: 29503650
[TBL] [Abstract][Full Text] [Related]
95. Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus.
Luk ADW; Ni K; Wu Y; Lam KT; Chan KW; Lee PP; Tu W; Mao H; Lau YL
Front Immunol; 2018; 9():1826. PubMed ID: 30147693
[TBL] [Abstract][Full Text] [Related]
96. A Registry Study of 240 Patients with X-Linked Agammaglobulinemia Living in the USA.
Hernandez-Trujillo V; Zhou C; Scalchunes C; Ochs HD; Sullivan KE; Cunningham-Rundles C; Fuleihan RL; Bonilla FA; Petrovic A; Rawlings DJ; de la Morena MT
J Clin Immunol; 2023 Aug; 43(6):1468-1477. PubMed ID: 37219739
[TBL] [Abstract][Full Text] [Related]
97. Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia.
Brunner C; Kreth HW; Ochs HD; Schuster V
J Clin Immunol; 2002 Jul; 22(4):244-51. PubMed ID: 12148599
[TBL] [Abstract][Full Text] [Related]
98. Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia.
Aghamohammadi A; Fiorini M; Moin M; Parvaneh N; Teimourian S; Yeganeh M; Goffi F; Kanegane H; Amirzargar AA; Pourpak Z; Rezaei N; Salavati A; Pouladi N; Abdollahzade S; Notarangelo LD; Miyawaki T; Plebani A
Int Arch Allergy Immunol; 2006; 141(4):408-14. PubMed ID: 16943681
[TBL] [Abstract][Full Text] [Related]
99. Hemizygous BTK Gene Variant Causing X-Linked Agammaglobulinemia in Two Siblings.
Saheb Sharif-Askari N; Hafezi S; Saheb Sharif-Askari F; Frommenwiler N; Halwani R
J Clin Immunol; 2023 Oct; 43(7):1533-1536. PubMed ID: 37341860
[No Abstract] [Full Text] [Related]
100. Impaired polysaccharide responsiveness without agammaglobulinaemia in three patients with hypomorphic mutations in Bruton Tyrosine Kinase-No detection by newborn screening for primary immunodeficiencies.
Krüger R; Baumann U; Borte S; Kölsch U; Lorenz MR; Keller B; Harder I; Warnatz K; Ehl S; Schwarz K; Wahn V; von Bernuth H
Scand J Immunol; 2020 Jan; 91(1):e12811. PubMed ID: 31378960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
